Cytokines and cardiac hypertrophy: Roles of angiotensin II and basic fibroblast growth factor

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue SUPPL. 3, 1996, Pages

  Kaye, David M ^a   Kelly, Ralph A ^a   Smith, Thomas W ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Angiotensin II; Basic fibroblast growth factor; Cardiac hypertrophy; Cytokines; Heparin binding epidermal growth factor

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN RECEPTOR; BASIC FIBROBLAST GROWTH FACTOR; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPIDERMAL GROWTH FACTOR; SARALASIN; SOMATOMEDIN; ANGIOTENSIN II; FIBROBLAST GROWTH FACTOR; HEPARIN; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HEPARIN-BINDING EGF-LIKE GROWTH FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; CONFERENCE PAPER; HEART HYPERTROPHY; HEART MUSCLE CELL; HEMODYNAMICS; NONHUMAN; PHENOTYPE; RAT; ANIMAL; CARDIOMEGALY; CYTOLOGY; DRUG EFFECT; HEART; HEART MUSCLE; METABOLISM; MOLECULAR WEIGHT; PATHOPHYSIOLOGY;

ANGIOTENSIN II; ANIMALS; CARDIOMEGALY; CYTOKINES; FIBROBLAST GROWTH FACTOR 2; HEART; HUMANS; MYOCARDIUM; MYOCYTES, CARDIAC; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTORS; HEPARIN; MOLECULAR WEIGHT; PHENOTYPE; RECEPTORS, ANGIOTENSIN;

EID: 0029753738     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (71)

1. Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP. Echocardiographically detected left ventricular hypertrophy: Prevalence and risk factors. Ann. Intern. Med. 1988; 108: 7-13.
2. Cooper RS, Simmons BE, Castaner A, Santhanam V, Ghali J, Mar M. Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed. Am. J. Cardiol. 1990; 65: 441-5.
3. Anversa P, Loud AV, Levicky V, Guideri G. Left ventricular failure induced by myocardial infarction. I. Myocyte hypertrophy. Am. J. Physiol. 1985; 248: H876-82.
4. Anversa P, Beghi C, Kikkawa Y, Olivetti G. Myocardial infarction in rats: Infarct size, myocyte hypertrophy and capillary growth. Circ. Res. 1986; 58: 26-37.
5. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: Fibrosis and renin-angiotensin-aldosterone system. Circulation 1991; 83: 1849-65.
6. Silver MA, Pick R, Brilla CG, Jalil JE, Janicki JS, Weber KT. Reactive and reparative fibrosis in the hypertrophied rat left ventricle: Two experimental models of myocardial fibrosis. Cardiovasc. Res. 1990; 24: 741-7.
7. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J. Clin. Invest. 1975; 56: 56-64.
8. Izumo S, Nadal-Ginard B, Mahdavi V. Proto-oncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc. Natl Acad. Sci. USA 1988; 85: 339-43.
9. Chien KR, Knowlton KU, Zhu H, Chien S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: Molecular studies of an adaptive physiologic response. FASEB J. 1991; 5: 3037-46.
10. Parker TG, Schneider MD. Growth factors, proto-oncogenes, and plasticity of the cardiac phenotype. Ann. Rev. Physiol. 1991; 53: 179-200.
11. Kaye D, Pimental D, Prasad S et al. Role of transiently altered sarcolemmal membrane permeability and bFGF release in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro. J. Clin. Invest. 1996; 97: 281-91.
12. Mann DL, Kent RL, Cooper GI. Load regulation of the properties of adult feline cardiocytes: Growth induction by cellular deformation. Circ. Res. 1989; 64: 1079-90.
13. Sadoshima J-I, Jahn L, Takahashi T, Kulik TJ, Izumo S. Molecular characterization of the stretch-induced adaptation of cultured cardiac cells: An in vitro model of load induced hypertrophy. J. Biol. Chem. 1992; 267: 10551-60.
14. Sadoshima J-I, Izumo S. Mechanical stretch rapidly acitivates multiple signal transduction pathways in cardiac myocytes: Potential involvement of an autocrine/paracrine mechanism. EMBO J. 1993; 12: 1681-92.
15. Kato S, Ivester CT, Zile MR, McDermott PJ. Growth effects of electrically stimulated contraction on adult feline cardiocytes in primary culture. Am. J. Physiol. 1995; 268: H2495-504.
16. Sachs F. Mechanical transduction by membrane ion channels: A mini review. Mol. Cell. Biochem. 1991; 104: 57-60.
17. Schwartz MA. Spreading of human endothelial cells on fibronectin or vitronectin triggers elevation of intracellular free calcium. J. Cell. Biol. 1993; 120: 1003-10.
18. Juliano RL, Haskill S. Signal transduction from the extracellular matrix. J. Cell Biol. 1993; 120: 577-85.
19. Fujimoto T, Nakade S, Miyaki A, Mikoshiba K, Ogawa K. Localization of inositol 1,4,5-triphosphate receptor-like protein in plasmalemmal caveolae. J. Cell Biol. 1992; 119: 1507-13.
20. Davies PF, Tripathi SC. Mechanical stress mechanisms and the cell: an endothelial paradigm. Circ. Res. 1993; 72: 239-45.
21. 1-adrenergic receptor interaction. Circ. Res. 1985; 56: 884-94.
22. Clark WA, Rudnick SJ, LaPres JJ, Andersen LC, LaPointe MC. Regulation of hypertrophy and atrophy in cultured adult heart cells. Circ. Res. 1993; 73: 1163-76.
23. 1-adrenergic stimulation. J. Biol. Chem. 1994; 269: 13490-6.
24. Cooper GI, Kent RL, Uboh CE, Thompson EW, Marino TA. Hemodynaimc versus adrenergic control of right ventricular hypertrophy. J. Clin. Invest. 1985; 75: 1430-44.
25. Pfeffer JM, Pfeffer MA, Mirsky I, Braunwald E. Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in spontaneously hypertensive rats. Proc. Natl Acad. Sci. USA 1982; 79: 3310-14.
26. Pfeffer JM, Pfeffer MA, Brunwald E. Influence of chronic captopril therapy on the infarcted left ventricle. Circ. Res. 1985; 57: 84-93.
27. Pfeffer MA, Lamas GA, Vanghan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilatation after myocardial infarction. N. Engl. J. Med. 1988; 319: 80-6.
28. Kromer EP, Riegger GA. Effects of long term angiotensin converting enzyme inhibition on myocardial hypertrophy in experimental aortic stenosis in the rat. Am. J. Cardiol. 1988; 62: 161-3.
29. Wakashima Y, Fouad FM, Tarazi RC. Regression of left ventricular hypertrophy from systemic hypertension by enalapril. Am. J. Cardiol. 1984; 53: 1044-9.
30. Baker KM, Chemin MI, Wixson SK, Aceto JF. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am. J. Physiol. 1990; 259: H324-32.
31. Kelly RA, Smith TW. Pharmacology of heart failure drugs. In: Braunwald E (ed.). Heart Disease, 5th edn. WB Saunders, Philadelphia. 1996 (in press).
32. 1 receptor subtype. Circ. Res. 1993; 73: 413-23.
33. Matsubara H, Kanasaki M, Murasawa S, Tsukaguchi Y, Nio Y, Inada M. Differential gene expression and regulation of angiotensin II receptor subtypes in rat cardiac fibroblasts and cardiomyocytes in culture. J. Clin. Invest. 1994; 93: 1592-601.
34. Sadoshima J-I, Izumo S. Signal transduction pathways of angiotensin II-induced c-fos gene expression in cardiac myocytes in vitro: Roles of phospholipid-derived second messengers. Circ. Res. 1993; 73: 424-38.
35. Schunkert H, Sadoshima J-I, Cornelius T et al. Angiotensin II-induced growth reponses in isolated adult rat hearts: Evidence for load-independent induction of cardiac protein synthesis by angiotensin II. Circ. Res. 1995; 76: 489-97.
36. Griendling KK, Murphy TJ, Alexander RW. Molecular biology of the renin-angiotensin system. Circulation 1993; 87: 1816-28.
37. 1 pathway. Nature 1995; 375: 247-50.
38. Kambayashi Y, Takahashi K, Bardhan S, Inagami T. Molecular structure and function of angiotesin type 2 receptor. Kidney Int. 1994; 46: 1502-4.
39. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice. Nature 1995; 377: 744-7.
40. Ichiki T, Labosky PA, Shiota C et al. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995; 377: 748-50.
41. Regitz-Zagrosek V, Friedel N, Heymann A et al. Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts. Circulation 1995; 91: 1461-71.
42. 2 receptor subtypes: An analaysis of hypertrophied rat hearts. Am. J. Physiol. 1994; 267: H844-52.
43. Dzau VJ, Re R. Tissue angiotensin system in cardiovascular medicine. A paradigm shift? Circulation 1994; 89: 493-8.
44. Dzau VJ, Re R. Evidence for the existence of renin in the heart. Circulation 1987; 73 (Suppl. I): I134-6.
45. Yamada H, Fabris B, Allen AM, Jackson B, Johnston C, Mendehlson FAO. Localization of angiotensin-converting enzyme in rat heart. Circ. Res. 1991; 68: 141-9.
46. Lindpaintner K, Jin M, Niedermaier N, Wilhelm MJ, Ganten D. Cardiac angiotensinogen and its local activation in the isolated perfused beating heart. Circ. Res. 1990; 67: 564-73.
47. Baker KM, Booz GW, Dostal DE. Cardiac actions of angiotensin II: Role of an intracardiac renin-angiotensin system. Annu. Rev. Physiol. 1992; 54: 227-41.
48. Dostal DE, Rothblum KN, Chemin MI, Cooper GR, Baker KM. Intracardiac generation of angiotensinogen and renin: A localized renin-angiotensin system in neonatal rat heart. Am. J. Physiol. 1992; 263: C838-50.
49. Dostal DE, Rothblum KN, Conrad K, Cooper GR, Baker KM. Detection of angiotensin I and II in cultured neonatal rat cardiac myocytes and fibroblasts. Am. J. Physiol. 1992; 263: C851-63.
50. Urata H, Kinoshita A, Misono KS, Bumpus FM, Husain A. Identification of a highly specific chymase as a major angiotensin-II forming enzyme in the human heart. J. Biol. Chem. 1990; 265: 22348-57.
51. Sadoshima J-I, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993; 75: 977-84.
52. Yamazaki T, Komuro I, Kudoh S et al. Angiotensin II partly mediates mechanical stress-induced cardiac hypertrophy. Circ. Res. 1995; 77: 258-65.
53. Nishida M, Springhorn JP, Kelly RA, Smith TW. Cell-cell signaling between adult rat ventricular myocytes and cardiac microvascular endothelial cells in heterotypic primary culture. J. Clin. Invest. 1993; 91: 1934-41.
54. Ungureanu D, Zengotita J, deUgarte D et al. De novo synthesis of angiotensin II by cardiac microvascular endothelial cells in vitro. Circulation 1993; 88 (Suppl. I): I191 (Abstract).
55. Kifor I, Dzau VJ. Endothelial renin-angiotensin pathway: Evidence for intracellular synthesis and secretion of angiotensins. Circ. Res. 1987; 60: 422-8.
56. Mason IJ. The ins and outs of fibroblast growth factors. Cell 1994; 78: 547-52.
57. Engelman GL, Dionne CA, Jaye MC. Acidic fibroblast growth factor and heart development. Role in myocyte proliferation and capillary angiogenesis. Circ. Res. 1993; 72: 7-19.
58. Parker TG, Chow KL, Schwartz RJ, Schneider M. Positive and negative control of the skeletal α-actin promoter in cardiac muscle. A proximal serum response element is sufficient for induction by basic fibroblast growth factor (FGF) but not for inhibition by acidic FGF. J. Biol. Chem. 1992; 267: 3343-50.
59. Kardami E, Fandrich R. Basic fibroblast growth factor in atria and ventricles of the vertebrate heart. J. Cell. Biol. 1989; 109: 1865-75.
60. Speir EV, Tanner AM, Gonzalez J, Farris A, Baird A, Casscells W. Acidic and basic fibroblast growth factors in adult rat heart myocytes. Localization, regulation in culture, and effects on DNA synthesis. Circ. Res. 1992; 71: 251-9.
61. McNeil PL, Muthukrishnan L, Warder E, D'Amore PA. Growth factors are released by mechanically wounded endothelial cells. J. Cell. Biol. 1989; 109: 811-22.
62. Clarke MSF, Caldwell RW, Chiao H, Miyake K, McNeil PL. Contraction-induced cell wounding and release of fibroblast growth factor in heart. Circ. Res. 1995; 76: 927-34.
63. Berger H-J, Prasad SK, Davidoff AJ et al. Continual electric field stimulation preserves contractile function of adult ventricular myocytes in primary culture. Am. J. Physiol. 1994; 266: H341-9.
64. Bogoyevitch MA, Glennon PE, Andersson MB et al. Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signalling pathways leading to to myocyte hypertrophy. J. Biol. Chem. 1994; 269: 1110-19.
65. Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 1991; 251: 936-9.
66. Higashiyama S, Abraham JA, Klagsbrun M. Heparin-binding EGF-like growth factor stimulation of smooth muscle migration: Dependence on interactions with cell surface heparin sulfate. J. Cell Biol. 1993; 122: 933-40.
67. Abraham JA, Damm D, Bajardi A, Miller J, Klagsbrun M. Heparin-binding EGF-like growth factor: Characterization of rat and mouse cDNA clones, protein domain conservation across species, and transcript expression in tissues. Biochem. Biophys. Res. Commun. 1993; 190: 125-133.
68. Perella MA, Maki T, Prasad S et al. Regulation of heparin-binding epidermal growth factor-like growth factor mRNA by hypertrophic stimuli in neonatal and adult rat cardiac myocytes. J. Biol. Chem. 1994; 269: 27045-50.
69. Froesch ER, Schmid C, Schwander J, Zapf J. Actions of insulin-like growth factors. Annu. Rev. Physiol. 1984; 47: 443-67.
70. Rechler MM, Nissley SP. The nature and regulation of the receptors for insulin-like growth factors. Annu. Rev. Physiol. 1985; 47: 425-42.
71. Donohue TJ, Dworkin LD, Lango MN et al. Induction of myocardial insulin-like growth factor-I gene expression in left ventricular hypertrophy. Circulation 1994; 89: 799-809.